Retrospective Study of Trabectedin in Soft Tissue Sarcomas

• Status: Completed
• Trial end date: 2018-10-02
• Target enrollment: 0
• Participant gender: All

Summary

This is an independent, observational, retrospective post marketing study on the use of trabectedin in a clinical setting.

A data collection on the clinical use of the drug will help to improve knowledge and might contribute to optimize the clinical use of the drug.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Italian Sarcoma Group
• Treatments: Trabectedin

Criteria

Inclusion Criteria:

• Patients who received trabectedin according to the approved indication in the period January 2010 December 2015

Exclusion Criteria:

• Trabectedin started before January 2010 and after December 2015

• Participation into clinical trials with trabectedin

• Clinical chart missing, empty, or not retrievable.